Non-AIDS-related Kaposi's sarcoma: A single-institution experience

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

316

HTML

2889

Figures (1-1)

194

Tables (1-4)

243

Sum=3642

Publishing Process of This Article

Item

Count

Browse

862

Download

750

Sum=1612

May 10, 2013 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Clin Oncol. May 10, 2013; 4(2): 52-57
Published online May 10, 2013. doi: 10.5306/wjco.v4.i2.52

Table 2 Chemotherapy agents employed in the sample population n (%)

	Patients number
Sytemic treatment¹
Vinblastine	17 (53.1)
Pegylated liposomal doxorubicin	8 (25)
Paclitaxel	5 (15.6)
Gemcitabine	1 (3.1)
Vinorelbine	1 (3.1)
Overall number of lines of systemic treatment received by the patient
1 line	26 (81.2)
> 1 line	6 (18.8)

¹The first systemic treatment delivered at our institution is reported.

Citation: Rescigno P, Trolio RD, Buonerba C, Fata GD, Federico P, Bosso D, Virtuoso A, Izzo M, Policastro T, Vaccaro L, Cimmino G, Perri F, Matano E, Delfino M, Placido SD, Palmieri G, Lorenzo GD. Non-AIDS-related Kaposi's sarcoma: A single-institution experience. World J Clin Oncol 2013; 4(2): 52-57
URL: https://www.wjgnet.com/2218-4333/full/v4/i2/52.htm
DOI: https://dx.doi.org/10.5306/wjco.v4.i2.52